Tabuteau Herriot's Form 4 filing
Axsome Therapeutics, Inc. (AXSM) · filed Dec 4, 2025
- Accession no.
- 0001193125-25-308354
- Filed
- Dec 4, 2025
- Trade date
- Dec 2-4, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $11.6M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tabuteau HerriotCIK 0001219927 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | MOption exerciseAcquired | +49,252 | $8.02 | +$395,001.04 | 56,481 | Direct | |
| Dec 2, 2025 | Common Stock | SSaleDisposed | −49,252 | $144.59F4 | −$7,121,346.68 | 7,229 | Direct | |
| Dec 3, 2025 | Common Stock | MOption exerciseAcquired | +20,163 | $8.02 | +$161,707.26 | 27,392 | Direct | |
| Dec 3, 2025 | Common Stock | SSaleDisposed | −20,163 | $146.94F5 | −$2,962,751.22 | 7,229 | Direct | |
| Dec 4, 2025 | Common Stock | MOption exerciseAcquired | +10,558 | $8.02 | +$84,675.16 | 17,787 | Direct | |
| Dec 4, 2025 | Common Stock | SSaleDisposed | −10,558 | $148.18F6 | −$1,564,484.44 | 7,229 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 2, 2025 | Common Stock | MOption exerciseDisposed | −49,252 | $0.00 | $0 | 202,545 | Direct | |
| Dec 3, 2025 | Common Stock | MOption exerciseDisposed | −20,163 | $0.00 | $0 | 182,382 | Direct | |
| Dec 4, 2025 | Common Stock | MOption exerciseDisposed | −10,558 | $0.00 | $0 | 171,824 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $141.79 and $149.23.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $142.66 and $148.39.
Referenced by the price of 1 transaction in Table I.
- F6
Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $146.77 and $149.41.
Referenced by the price of 1 transaction in Table I.